These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 30267054)
1. Addressing the Tuberculosis Epidemic: 21st Century Research for an Ancient Disease. Fauci AS JAMA; 2018 Oct; 320(13):1315-1316. PubMed ID: 30267054 [No Abstract] [Full Text] [Related]
2. Research resources for tuberculosis at the National Institute of Allergy and Infectious Diseases. NIH, DMID TB program Tuberculosis (Edinb); 2013 Jan; 93(1):6-11. PubMed ID: 23385001 [TBL] [Abstract][Full Text] [Related]
3. The diabolical genius of an ancient scourge. Lehrman S Sci Am; 2013 Jul; 309(1):80-5. PubMed ID: 23821868 [No Abstract] [Full Text] [Related]
4. New tools for global tuberculosis control: are we any closer? Yew WW; Borgdorff MW; Enarson DA Int J Tuberc Lung Dis; 2012 Jul; 16(7):855-6. PubMed ID: 22687496 [No Abstract] [Full Text] [Related]
5. Alimuddin Zumla: infectious diseases guru and survivor. Kirby T Lancet Infect Dis; 2013 Apr; 13(4):301. PubMed ID: 23531387 [No Abstract] [Full Text] [Related]
6. Implementing the End TB Strategy: Well begun will be half done. Uplekar M Indian J Tuberc; 2015 Apr; 62(2):61-3. PubMed ID: 26117472 [No Abstract] [Full Text] [Related]
7. Profile: Anthony Fauci. The view from the top of the HIV/AIDS world. Cohen J Science; 2012 Jul; 337(6091):152-3. PubMed ID: 22798580 [No Abstract] [Full Text] [Related]
8. Tuberculosis: An Epidemic Perpetuated by Health Inequalities. Szkwarko D; Bouton TC; Rybak NR; Carter EJ; Chiang SS R I Med J (2013); 2019 Sep; 102(7):47-50. PubMed ID: 31480821 [TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. Fauci AS; J Infect Dis; 2008 Jun; 197(11):1493-8. PubMed ID: 18426366 [No Abstract] [Full Text] [Related]
10. An urgent call for a stronger, louder voice for TB vaccine advocacy. Tameris M; Gelderbloem SJ; Rustomjee R Tuberculosis (Edinb); 2013 May; 93(3):277-8. PubMed ID: 23499046 [No Abstract] [Full Text] [Related]
11. Tuberculosis control in the 21st century. Sepkowitz KA Emerg Infect Dis; 2001; 7(2):259-62. PubMed ID: 11294719 [TBL] [Abstract][Full Text] [Related]
14. Tuberculosis control: challenges of an ancient and ongoing epidemic. Cummings KJ Public Health Rep; 2007; 122(5):683-92. PubMed ID: 17877317 [No Abstract] [Full Text] [Related]
15. [Tuberculosis, a story still relevant]. Locht C Med Sci (Paris); 2016; 32(6-7):535-6. PubMed ID: 27406748 [No Abstract] [Full Text] [Related]
16. From AIDS to TB vaccines--A career in infectious diseases and translational vaccinology. McShane H Hum Vaccin Immunother; 2016; 12(1):5-7. PubMed ID: 26558654 [No Abstract] [Full Text] [Related]
17. Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program. Izzo AA Curr Opin Immunol; 2017 Aug; 47():78-84. PubMed ID: 28750280 [TBL] [Abstract][Full Text] [Related]
18. Optimal control for a tuberculosis model with reinfection and post-exposure interventions. Silva CJ; Torres DF Math Biosci; 2013 Aug; 244(2):154-64. PubMed ID: 23707607 [TBL] [Abstract][Full Text] [Related]
20. Understanding the human immune system in the 21st century: the Human Immunology Project Consortium. Poland GA; Quill H; Togias A Vaccine; 2013 Jun; 31(28):2911-2. PubMed ID: 23648045 [No Abstract] [Full Text] [Related] [Next] [New Search]